How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.

Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J (2014) 1.74

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy (2016) 1.39

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int (2015) 1.33

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04

Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy (2012) 0.93

Recommendations for appropriate sublingual immunotherapy clinical trials. World Allergy Organ J (2014) 0.86

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma. J Negat Results Biomed (2013) 0.80

Allergen Immunotherapy (AIT): a prototype of Precision Medicine. World Allergy Organ J (2015) 0.78

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy (2016) 0.75

A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients. Allergy (2016) 0.75

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96

Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol (1997) 8.51

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol (2006) 6.91

Diary keeping in asthma: comparison of written and electronic methods. BMJ (1993) 6.77

Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86

Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70

Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect Immun (1991) 3.62

Sulphasalazine in rheumatoid arthritis. Br Med J (1980) 3.53

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20

A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19

Medication errors at the administration stage in an intensive care unit. Intensive Care Med (1999) 3.16

A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16

Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10

Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy (2006) 2.94

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Am J Respir Crit Care Med (2000) 2.92

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine. Lancet (1994) 2.78

Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (2007) 2.77

Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur J Clin Nutr (2012) 2.72

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51

Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis (2004) 2.41

Side-effects of allergen-specific immunotherapy: a prospective multi-centre study. Clin Exp Allergy (2006) 2.36

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J (2001) 2.35

Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract (2000) 2.34

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29

Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. J Allergy Clin Immunol (2005) 2.21

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2000) 2.19

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy (2004) 2.13

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13

Mortality and coronary heart disease among men studied for 23 years. Arch Intern Med (1971) 2.09

EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy (2005) 2.07

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05

An alternative to "brutacaine": a comparison of low dose intramuscular ketamine with intranasal midazolam in children before suturing. J Accid Emerg Med (1998) 2.03

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J (2010) 2.01

Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy (2003) 2.01

Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy (2008) 1.97

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

Human beta-defensins and toll-like receptors in the upper airway. Allergy (2003) 1.96

Impaired cerebral vasoreactivity after embolization of arteriovenous malformations: assessment with serial acetazolamide challenge xenon CT. AJNR Am J Neuroradiol (1991) 1.96

Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS (1998) 1.94

A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. Respir Med (2010) 1.92

Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax (2007) 1.89

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest (1998) 1.84

Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84